Citadel Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,250
Closed -$55.4K 14598
2024
Q4
$55.4K Sell
2,250
-75
-3% -$3.27K ﹤0.01% 12288
2024
Q3
$125K Buy
+2,325
New +$124K ﹤0.01% 10814
2023
Q2
Sell
-25
Closed -$1.26K 14436
2023
Q1
$1.26K Buy
+25
New +$1.48K ﹤0.01% 14334

Other funds holding CNBS

Citadel Advisors's CNBS Position: Q1 2026 in Review

Citadel Advisors opened a new position in Amplify Seymour Cannabis ETF (CNBS) in Q1 2026: 14,788 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #10296 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CNBS as recently as Q4 2024.

Citadel Advisors first reported a position in CNBS in Q2 2021 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold CNBS as of Q1 2026.

  • Citadel Advisors held 14,788 shares of Amplify Seymour Cannabis ETF worth $326K as of Q1 2026.
  • Amplify Seymour Cannabis ETF was a new Citadel Advisors position in Q1 2026.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10296 holding.
  • Citadel Advisors first reported a position in Amplify Seymour Cannabis ETF in Q2 2021 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.